New Funding Opportunities to Assist Innovative Small Businesses Announced: NCI News Note
The National Cancer Institute Small Business Innovation Research (SBIR) program recently announced $8 million in new contract funding opportunities to assist small businesses with cancer research and technology development. The 12 new contract funding opportunities range across novel technology areas, including anti-cancer agents, diagnostics, radiotherapy, device development, nanotechnology-based sensors, and imaging technology.
Among the 12 opportunities, the NCI SBIR program announced three NIH Technology Transfer (TT) inventions released as contract topics. The goal of each SBIR-TT topic is to identify a small business which can obtain both SBIR funding and licenses. Ultimately, the business should perform the necessary research and development to advance the technology towards commercialization. The FY2012 technology transfer contract topics include: Simplified Tumor Microarray Instrument for Clinical and Research Settings; High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy; and A Low Molecular Weight Thyroid-Stimulating Hormone Receptor Agonist for Thyroid Cancer (sponsored by NIH’s NIDDK). For a full list of contract funding opportunities currently available, please go to http://sbir.cancer.gov/funding/contracts.